Peter Messiaen
Overview
Explore the profile of Peter Messiaen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanhamel J, Reyniers T, Vuylsteke B, Callens S, Nostlinger C, Huis In t Veld D, et al.
J Int AIDS Soc
. 2024 Jul;
27 Suppl 1:e26260.
PMID: 38965986
Introduction: In Belgium, oral HIV pre-exposure prophylaxis (PrEP) is primarily provided in specialized clinical settings. Optimal implementation of PrEP services can help to substantially reduce HIV transmission. However, insights into...
2.
Ruytinx P, Vandormael P, Fraussen J, Pieters Z, Thonissen S, Hellings N, et al.
Sci Rep
. 2023 Nov;
13(1):19322.
PMID: 37935729
The immune response in patients with Coronavirus Disease 2019 (COVID-19) is highly variable and is linked to disease severity and mortality. However, antibody and cytokine responses in the early disease...
3.
Nasreddine R, Florence E, Yombi J, Henrard S, Darcis G, van Praet J, et al.
HIV Med
. 2023 Apr;
24(8):914-924.
PMID: 37038245
Objectives: Our objective was to evaluate the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in a real-world setting in Belgium. Methods: This was a retrospective, multicentre cohort study involving...
4.
Van Praet J, Serrien B, Ausselet N, Darcis G, Demeester R, De Munter P, et al.
J Acquir Immune Defic Syndr
. 2023 Feb;
93(2):e4-e5.
PMID: 36787727
No abstract available.
5.
Karver T, Pascual-Bernaldez M, Berni A, Hnoosh A, Castagna A, Messiaen P, et al.
AIDS Patient Care STDS
. 2023 Jan;
37(1):53-59.
PMID: 36626155
Cabotegravir and rilpivirine long-acting (LA) antiretroviral therapy (ART) demonstrated similar safety and efficacy in maintaining viral suppression among participants switching from daily oral to LA ART in the Extension Phase...
6.
Nasreddine R, Yombi J, Darcis G, Florence E, Allard S, De Scheerder M, et al.
HIV Med
. 2022 Aug;
24(3):267-278.
PMID: 35938381
Objectives: A paradigm shift from three-drug regimens to two-drug regimens (2DRs) is currently taking place in real-world clinical practice. This study aimed to describe the efficacy, durability, and tolerability of...
7.
DOnofrio V, Heylen D, Pusparum M, Grondman I, Vanwalleghem J, Meersman A, et al.
J Intensive Care
. 2022 Mar;
10(1):13.
PMID: 35264246
Background: Sepsis is a life-threatening organ dysfunction. A fast diagnosis is crucial for patient management. Proteins that are synthesized during the inflammatory response can be used as biomarkers, helping in...
8.
Vermeersch S, Demeester R, Ausselet N, Callens S, De Munter P, Florence E, et al.
BMC Health Serv Res
. 2022 Jan;
22(1):13.
PMID: 34974833
Background: HIV patients face considerable acute and chronic healthcare needs and battling the HIV epidemic remains of the utmost importance. By focusing on health outcomes in relation to the cost...
9.
DOnofrio V, Meersman A, Magerman K, Waumans L, van Halem K, Cox J, et al.
Int J Antimicrob Agents
. 2021 Jun;
58(3):106379.
PMID: 34161787
Objectives: To perform an audit of empirical antibiotic therapy (EAT) of sepsis at the emergency department and to analyse the impact of an antimicrobial stewardship (AMS) programme on process and...
10.
Van Steenkiste E, Schoofs J, Gilis S, Messiaen P
Acta Clin Belg
. 2021 Mar;
77(3):533-540.
PMID: 33779529
Objectives: A prospective longitudinal single-centre study to assess the mental health impact of COVID-19 on nurses working in the frontline during the first wave of COVID-19 hospitalizations in Belgium, 2020....